Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) EPS (Weighted Average and Diluted) (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$0.27 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 22.73% to -$0.27 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.06 through Dec 2025, up 1.85% year-over-year, with the annual reading at -$1.05 for FY2025, 2.78% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.27 in Q4 2025 for Rapid Micro Biosystems, down from -$0.26 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.2 in Q4 2021 to a low of -$37.89 in Q1 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$3.11 across 5 years, with a median of -$0.31 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 103.25% in 2021 and later tumbled 131.67% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at $1.2 in 2021, then crashed by 131.67% to -$0.38 in 2022, then skyrocketed by 31.58% to -$0.26 in 2023, then rose by 15.38% to -$0.22 in 2024, then decreased by 22.73% to -$0.27 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for RPID at -$0.27 in Q4 2025, -$0.26 in Q3 2025, and -$0.27 in Q2 2025.